Navigation Links
Herborium(R) Group Discusses an Aftermath of the Ban of Diane-35 Acne Drug Due to Number of Deaths
Date:2/4/2013

FORT LEE, N.J., Feb. 4, 2013 /PRNewswire/ -- Herborium Group, Inc., (OTC Pink: HBRM) www.herborium.com, a Botanical Therapeutics® Company discusses an impact of a ban of Bayer's Diana-35 acne drug in Europe, and a follow up investigation in Canada, on Herborium' s all botanical acne treatment -AcnEase®.

Diane-35 is a hormonal drug used to treat hormonal acne, especially those resulting from too much of androgens (male hormones). It is also an oral contraceptive (birth control pill). Diane-35 is not approved in the US but it was available in Canada. Like many other drugs Diane-35 found its way to US consumers though so called "gray marketing".

Diane-35 is presently investigated in Europe and Canada for number of deaths, caused by blood clots, and for non-fatal cases of thrombosis and arterial thrombosis associated with a use of a drug.

In September 2011, the U.S. Food and Drug Administration (FDA) has informed the public that it has not yet reached a conclusion, but remains concerned, about the potential increased risk of blood clots with the use of drospirenone-containing birth control pills.  Number of US approved contraceptive pills including very popular Yasmin and Yuz were put on a warning list.  Despite of the warning, birth control pills are still rather liberally prescribed to women with acne even if their sexual activity is not a factor.

AcnEase® is all botanical ingredients based product that DOES NOT INCLUDE ANY ESTROGEN. Furthermore, AcnEase® also DOES NOT include any phytoestrogens   (plant-derived estrogen-like substance). As phytoestrogens may be considered safer that those made chemically they still act in a similar way and therefore may not be suitable or safe for some consumers especially teens, women that want to become pregnant, those who are pregnant or nursing, and of course men suffering from hormonal acne.

"We are deeply saddened by a death and potential serious health implication among Diane-35 patients. We are also determined to reiterate to our investors and customers that a decision to base Herborium's differential advantage on the use of proprietary, validated and safe botanical formulas has once again been proven correct and most advantageous both strategically and ethically. We will continue to provide safe and up to 96% effective AcnEase® to acne sufferers in all markets, and to grow our market share in the multi-billion dollar world-wide acne treatment sector," commented Dr. Agnes P. Olszewski , CEO and Chairwomen of Herborium Group.  

About Herborium Group, Inc. 

Herborium Group, Inc., a Botanical Therapeutics® company, focuses on developing, licensing, and marketing proprietary, botanical based medicinal products to consumers and healthcare professionals.  The Company uses clinical validation to establish and maintain a differential advantage.  The company sells its products in the US and Europe. For more information, please visit www.herborium.com and www.acnease.com

One of our most important responsibilities is to communicate with shareholders in an open and direct manner. Comments are based on current management expectations, and are considered "forward-looking statements," generally preceded by words such as "plans," "expects," "believes," "anticipates," or "intends." We cannot promise future returns. Our statements reflect our best judgment at the time, and we disclaim any obligation to update or alter forward-looking statements as the result of new information or future events. The Company urges investors to review the risks and uncertainties contained within its filings with the OTC Markets and/or Securities and Exchange Commission.

For more information please inquire: Investorsrelations@herborium.com

 


'/>"/>
SOURCE Herborium Group, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. InternetArray Collaborates with Health Sciences Group to Fund Medical Marijuana Social Media/Mobile Apps Development
2. NSF International Acquires the INASSA Group LLC, a Peruvian Leader in Analytical Testing, Certification, Inspection and Training for the Seafood/Fishing, Food and Pharmaceutical/Medical Industries
3. Health Diagnostic Laboratory, Inc. and Global Genomics Group join forces to form a new scientific process
4. Foundation Venture Capital Group Invests In Start-Up Working to Reduce Side Effects of Parkinsons Treatment
5. Pro-Dex, Inc. And AO Partners Group Jointly Announce Voting Results
6. Simcere Pharmaceutical Group Announces Sale of Equity Interest in Shanghai Celgen
7. Maximizing the Effectiveness of Market Research Groups through Outsourcing and Automation
8. Global Medical Device Marketing Groups Respond to Internal Cost Pressures
9. NYSE Hot Stocks Earnings Forecast: Wells Fargo, Eli Lilly, Berkshire Hathaway, Coca-Cola, Valero Energy, and Altria Group
10. Earnings Forecast Stock Alerts: American International Group, Teva Pharmaceutical, CSX, Exxon Mobil, Lowes, and Seagate
11. Cloudnine Group of Hospitals Delivers 12 Babies by Mid-day on 12/12/12
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... Oct. 11, 2017  BioPharmX Corporation (NYSE MKT: BPMX) ... developed an innovative way to use nonlinear optical imaging ... of new drugs. ... Conference will show how researchers from BioPharmX and the ... School used a suite of imaging techniques in what ...
(Date:10/10/2017)...   West Pharmaceutical Services, Inc. (NYSE: WST), ... administration, today shared the results of a study highlighting ... intradermal administration of polio vaccines. The study results were ... 2017 by Dr. Ondrej Mach , Clinical Trials ... (WHO), and recently published in the journal Vaccine. ...
(Date:10/4/2017)... , Oct. 4, 2017 OBP ... self-contained, illuminating medical devices, today announced regulatory approval ... Surveillance Agency (or Agência Nacional de Vigilância Sanitária ... single-use, cordless surgical retractor with integrated LED light ... access, illumination and exposure of a tissue pocket ...
Breaking Medicine Technology:
(Date:10/13/2017)... Nevada (PRWEB) , ... October 13, 2017 , ... ... Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil ... required and providing a CBD form that can be easily incorporated into liquid products, ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Many families have ... many long-term care insurance companies have a waiver for care if the client has ... period, when the family pays for care, is often waived, so the benefits from ...
(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
(Date:10/13/2017)... ... 2017 , ... “America On The Brink”: the Christian history of the United ... the creation of published author, William Nowers. Captain Nowers and his wife, Millie, ... spent thirty years in the Navy. Following his career as a naval aviator ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s to ... and tested to meet the highest standard. , These products are also: ...
Breaking Medicine News(10 mins):